Seminars in Liver Disease

Lencioni, Riccardo; Llovet, Josep M: Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

Weinberg, Ethan M.; Palecki, Julia; Reddy, K. Rajender: Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis

Llovet, Josep M.; Brú, Concepció; Bruix, Jordi: Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

Mohr, Ashley M.; Mott, Justin L.: Overview of MicroRNA Biology

Alegre, Fernando; Pelegrin, Pablo; Feldstein, Ariel E.: Inflammasomes in Liver Fibrosis

Younes, Ramy; Bugianesi, Elisabetta: NASH in Lean Individuals

Lizardo-Thiebaud, Maria J.; Cervantes-Alvarez, Eduardo; Limon-de la Rosa, Nathaly; Tejeda-Dominguez, Farid; Palacios-Jimenez, Mildred; Méndez-Guerrero, Osvely; Delaye-Martinez, Marco; Rodriguez-Alvarez, Fatima; Romero-Morales, Beatriz; Liu, Wei-Hui; Huang, Christene A.; Kershenobich, David; Navarro-Alvarez, Nalu: Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients

Feld, Jordan J.: Interferon-Free Strategies with a Nucleoside/Nucleotide Analogue

Campana, Lara; Iredale, John P.: Regression of Liver Fibrosis

Lazarus, Jeffrey V.; Safreed-Harmon, Kelly; Thursz, Mark R.; Dillon, John F.; El-Sayed, Manal H.; Elsharkawy, Ahmed M.; Hatzakis, Angelos; Jadoul, Michel; Prestileo, Tullio; Razavi, Homie; Rockstroh, Jürgen K.; Wiktor, Stefan Z.; Colombo, Massimo: The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations